Anebulo Pharmaceuticals
Stock Forecast, Prediction & Price Target
Anebulo Pharmaceuticals Financial Estimates
Anebulo Pharmaceuticals Revenue Estimates
Anebulo Pharmaceuticals EBITDA Estimates
Anebulo Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | 6/30/2028 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $16.82M Low: $16.82M High: $16.82M avg. 0% | Avg: $27.30M Low: $27.30M High: $27.30M avg. 62.26% | Avg: $78.75M Low: $78.75M High: $78.75M avg. 188.40% | |
Net Income
% change YoY
| $-6.81M N/A | $-11.73M -72.21% | $-8.20M 30.09% | Avg: $-24.36M Low: $-17.80M High: $-16.29M avg. -197.04% | Avg: $-13.66M Low: $-13.66M High: $-13.66M avg. 43.90% | Avg: $15.79M Low: $15.79M High: $15.79M avg. 215.59% | |
EBITDA
% change YoY
| $-6.82M N/A | $-11.78M -72.63% | $-8.05M 31.68% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$0.29 N/A | -$0.47 -62.06% | -$0.32 31.91% | Avg: -$0.68 Low: -$0.71 High: -$0.65 avg. -112.5% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 19.85% | Avg: $0.63 Low: $0.63 High: $0.63 avg. 215.59% | |
Operating Expenses
% change YoY
| $6.83M N/A | $11.78M 72.49% | $8.30M -29.48% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is Anebulo Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.81% in 2026-2028.
We have gathered data from 2 analysts. Their low estimate is -17.80M, average is -24.36M and high is -16.29M.
What is Anebulo Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 83.55% in 2026-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $16.82M, average is $16.82M and high is $16.82M.
What is Anebulo Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 40.98% in 2026-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.71, average is -$0.68 and high is $-0.65.
What is the best performing analyst?
In the last twelve months analysts have been covering Anebulo Pharmaceuticals stock. The most successful analyst is Boobalan Pachaiyappan.